MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer

MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer

Neoadjuvant chemoradiotherapy (CRT) followed by total mesorectal excision has emerged as the standard treatment for locally advanced rectal cancer (LARC) patients. However, many cases do not respond to neoadjuvant CRT, suffering unnecessary toxicities and surgery delays. Thus, identification of pred...

Full description

Bibliographic Details
Main Authors: Cristina Caramés, Ion Cristobal, Víctor Moreno, Juan P. Marín, Paula González-Alonso, Blanca Torrejón, Pablo Minguez, Ana Leon, José I. Martín, Roberto Hernández, Manuel Pedregal, María J. Martín, Delia Cortés, Damian García-Olmo, María J. Fernández, Federico Rojo, Jesús García-Foncillas
Format: Article
Language:English
Published: MDPI AG 2016-06-01
Series:International Journal of Molecular Sciences
Subjects:
miR-31
neoadjuvant chemoradiotherapy
rectal cancer
prognosis
Online Access:http://www.mdpi.com/1422-0067/17/6/878

Internet

http://www.mdpi.com/1422-0067/17/6/878

Similar Items